Cardiometabolic RNA and next-generation lipid drug trial starts by region

3 regions, 2020 to 2025

30 Global, 2025

Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 0 to 128. Latest values: Global 30 (2025); United States 26 (2025); China 12 (2025). 0 30 60 90 120 150 2020 2021 2022 2023 2024 2025 Global United States China
Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 0 to 128. Latest values: Global 30 (2025); United States 26 (2025); China 12 (2025). 0 50 100 150 2020 2021 2022 2023 2024 2025 Global United States China
Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 0 to 128. Latest values: Global 30 (2025); United States 26 (2025); China 12 (2025). 0 50 100 150 2020 2021 2022 2023 2024 2025 Global United States China
View the underlying data
Cardiometabolic RNA and next-generation lipid drug trial starts by region: 3 regions, 2020 to 2025
Region Period Type Value
Global 2025 Actual 30
Global 2024 Actual 51
Global 1 Jan 2023 to 27 Sep 2026 Actual 128
Global 2022 Actual 32
Global 2021 Actual 28
Global 2020 Actual 6
United States 2025 Actual 26
United States 2024 Actual 35
United States 1 Jan 2023 to 27 Sep 2026 Actual 90
United States 2022 Actual 25
United States 2021 Actual 22
United States 2020 Actual 6
China 2025 Actual 12
China 2024 Actual 12
China 1 Jan 2023 to 27 Sep 2026 Actual 35
China 2022 Actual 3
China 2021 Actual 4
China 2020 Actual 0
Chart: StatOrigin · Source: ClinicalTrials.gov · statorigin.org CC BY 4.0